Moreover, findings of fixed drug eruptions, SJS/TEN, drug-induced pruritus, and Sweet syndrome/acute febrile neutrophilic dermatosis have been linked with the commencement of SGLT2 inhibitors and subsided after discontinuing them. Here, SLC5A2 is linked to toxic epidermal necrolysis.